This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Implications for the Importance of Urinary MHPG

Peter A. Blombery, MD, PhD; Irwin J. Kopin, MD; Edna K. Gordon; Sanford P. Markey, PhD; Michael H. Ebert, MD

Arch Gen Psychiatry. 1980;37(10):1095-1098.

Abstract
• Deuterium-labelled 4-hydroxy-3-methoxyphenylglycol (MHPG), when administered intravenously, is rapidly converted to 4-hydroxy-3-methoxymandelic acid (or vanillylmandelic acid [VMA]) or conjugates of MHPG. Since over half of either racemic D,L-MHPG or the natural D-MHPG is converted to VMA and since about half of urinary VMA is derived from MHPG, estimates of the proportion of urinary MHPG derived from the brain must be revised. The results indicate that only about one fifth of urinary MHPG is derived from the brain, and clearly urinary MHPG cannot be used as a valid index of brain norepinephrine metabolism. While these observations do not alter the value of urinary MHPG as a predictor of therapeutic response or in subclassifying affective disorders, it is clear that new research questions must be formulated and appropriate investigations completed before the relationship of urinary MHPG to affective disorders is understood.

Author Affiliations
From Baker Medical Research Institute, Prahran, Victoria, Australia (Dr Blombery); and the Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md (Drs Kopin, Markey, and Ebert and Ms Gordon). Dr Blombery was a Guest Worker at the Laboratory of Clinical Science from April 24, 1977 to Dec 17, 1979; he was supported by the Royal Australian College of Physicians and Surgeons from April 24, 1977 to May 8, 1979, at which time he received a Fogarty International Fellowship.

Footnotes
Accepted for publication May 8, 1980.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Eisenhofer et al.
Pharmacol. Rev. 2004;56:331-349.
ABSTRACT | FULL TEXT  

Biologic Markers and Neurochemical Correlates of Agitation and Psychosis in Dementia
Kirby and Lawlor
J Geriatr Psychiatry Neurol 1995;8:S2-S7.
ABSTRACT  

Noradrenergic Dysregulation During Discontinuation of Cocaine Use in Addicts
McDougle et al.
Arch Gen Psychiatry 1994;51:713-719.
ABSTRACT  

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

Plasma 3-Methoxy-4-Hydroxyphenylglycol Changes Associated With Clinical State and Schizophrenic Subtype
Ko et al.
Arch Gen Psychiatry 1988;45:842-846.
ABSTRACT  

High Intercorrelations Among Urinary Outputs of Norepinephrine and Its Major Metabolites: A Replication in Depressed Patients and Controls
Roy et al.
Arch Gen Psychiatry 1988;45:158-161.
ABSTRACT  

Afternoon Continuous Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol and Age: Distinctive Biologic Subgroups of Endogenous Depression?
Halbreich et al.
Arch Gen Psychiatry 1987;44:804-812.
ABSTRACT  

Lithium Carbonate Treatment of Mania: Cerebrospinal Fluid and Urinary Monoamine Metabolites and Treatment Outcome
Swann et al.
Arch Gen Psychiatry 1987;44:345-354.
ABSTRACT  

Norepinephrine and Dopamine Metabolites and Educational Variables in Boys With Attention Deficit Disorder and Hyperactivity
Shekim et al.
J Child Neurol 1987;2:50-56.
ABSTRACT  

{alpha}2-Adrenergic Receptor Function in Depression: The Cortisol Response to Yohimbine
Price et al.
Arch Gen Psychiatry 1986;43:849-858.
ABSTRACT  

Stimulants, Urinary Catecholamines, and Indoleamines in Hyperactivity: A Comparison of Methylphenidate and Dextroamphetamine
Zametkin et al.
Arch Gen Psychiatry 1985;42:251-255.
ABSTRACT  

Excretion of Catecholamine Metabolites During Methadone Maintenance and Withdrawal
De Leon-Jones et al.
Arch Gen Psychiatry 1983;40:841-847.
ABSTRACT  

Electroconvulsive Treatment and Lithium Carbonate: Their Effects on Norepinephrine Metabolism in Patients With Primary, Major Depressions
Linnoila et al.
Arch Gen Psychiatry 1983;40:677-680.
ABSTRACT  

Increased Plasma MHPG in Dexamethasone-Resistant Depressed Patients
Jimerson et al.
Arch Gen Psychiatry 1983;40:173-176.
ABSTRACT  

Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol
Kopin et al.
Science 1983;219:73-75.
ABSTRACT  

High Correlation of Norepinephrine and Its Major Metabolite Excretion Rates
Linnoila et al.
Arch Gen Psychiatry 1982;39:521-523.
ABSTRACT  

The Peripheral Kinetics of Norepinephrine in Depressive Illness
Esler et al.
Arch Gen Psychiatry 1982;39:295-300.
ABSTRACT  

Plasma MHPG in Rapid Cyclers and Healthy Twins
Jimerson et al.
Arch Gen Psychiatry 1981;38:1287-1290.
ABSTRACT